#BEGIN_DRUGCARD DB02549

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C12H18N2O12P2

# Chemical_IUPAC_Name:
[({[(2R,3S,5S)-3-(acetyloxy)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3'-O-Acetylthymidine-5'-Diphosphate

# HET_ID:
ATY

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H18N2O12P2/c1-6-4-14(12(17)13-11(6)16)10-3-8(24-7(2)15)9(25-10)5-23-28(21,22)26-27(18,19)20/h4,8-10H,3,5H2,1-2H3,(H,21,22)(H,13,16,17)(H2,18,19,20)/t8-,9+,10-/m0/s1

# InChI_Key:
InChIKey=UWSIAAWKEICIJY-AEJSXWLSSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2549

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
444.225

# Molecular_Weight_Mono:
444.033497074

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DZT

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.41

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
5.43e+00 g/l

# Primary_Accession_No:
DB02549

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936421

# PubChem_Substance_ID:
46506629

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00591

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)O[C@H]1C[C@H](O[C@@H]1CO[P@](O)(=O)OP(O)(O)=O)N1C=C(C)C(=O)NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:15 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
X56793

# Drug_Target_1_GenBank_ID_Protein:
581655

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rfbC

# Drug_Target_1_Gene_Sequence:
>552 bp
GTGATGATTGTGATTAAAACAGCAATACCAGATGTCTTGATCTTAGAGCCTAAAGTTTTT
GGCGATGAGAGGGGATTCTTTTTTGAAAGTTATAACCAGCAGACCTTTGAAGAGTTGATT
GGACGTAAAGTTACATTTGTTCAAGATAATCATTCAAAATCCAAAAAGAACGTACTCAGA
GGGCTACATTTTCAGAGAGGAGAAAATGCACAGGGGAAGTTAGTTCGTTGTGCTGTCGGT
GAGGTTTTTGATGTTGCGGTCGATATCCGAAAAGAATCGCCTACTTTTGGTCAATGGGTT
GGTGTAAATCTGTCTGCTGAGAATAAGCGACAGCTTTGGATTCCAGAAGGTTTTGCTCAT
GGTTTTGTTACTCTTAGTGAGTATGCAGAGTTTCTGTACAAAGCAACTAATTATTACTCA
CCTTCATCGGAAGGTAGCATTCTATGGAATGATGAGGCAATAGGTATTGAATGGCCTTTT
TCTCAGCTGCCTGAGCTTTCAGCAAAAGATGCTGCAGCACCTTTACTGGATCAAGCCTTG
TTAACAGAGTAA

# Drug_Target_1_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_1_General_References:
10802738	Giraud MF, Leonard GA, Field RA, Berlind C, Naismith JH: RmlC, the third enzyme of dTDP-L-rhamnose pathway, is a new class of epimerase. Nat Struct Biol. 2000 May;7(5):398-402.
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1710759	Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR: Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol. 1991 Mar;5(3):695-713.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3028

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
20664

# Drug_Target_1_Name:
dTDP-4-dehydrorhamnose 3,5-epimerase

# Drug_Target_1_Number_of_Residues:
183

# Drug_Target_1_PDB_ID:
1DZR

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00908	dTDP_sugar_isom

# Drug_Target_1_Protein_Sequence:
>dTDP-4-dehydrorhamnose 3,5-epimerase
MMIVIKTAIPDVLILEPKVFGDERGFFFESYNQQTFEELIGRKVTFVQDNHSKSKKNVLR
GLHFQRGENAQGKLVRCAVGEVFDVAVDIRKESPTFGQWVGVNLSAENKRQLWIPEGFAH
GFVTLSEYAEFLYKATNYYSPSSEGSILWNDEAIGIEWPFSQLPELSAKDAAAPLLDQAL
LTE

# Drug_Target_1_Reaction:
dTDP-4-dehydro-6-deoxy-D-glucose = dTDP-4-dehydro-6-deoxy-L-mannose

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
dTDP-4-dehydro-6-deoxy-D-glucose = dTDP-4- dehydro-6-deoxy-L-mannose

# Drug_Target_1_SwissProt_ID:
P26394

# Drug_Target_1_SwissProt_Name:
RMLC_SALTY

# Drug_Target_1_Synonyms:
EC 5.1.3.13
dTDP-4-keto-6- deoxyglucose 3,5-epimerase
dTDP-L-rhamnose synthetase

# Drug_Target_1_Theoretical_pI:
4.76

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02549
